HIGHLIGHTS
- who: Joaquin A. Anguera from the Participants The study was approved by the Committee on Human Research at the University of California, San Francisco, and retrospectively registered on ISRCTN registry [ISRCTN [66423499] to distinguish the goals and approach taken here from those of the u2018parent` registration (clinicaltrialsgov submission NCT03032796). This study was designed to gauge the feasibility and potential efficacy of using the BBT intervention compared to an expectancy matched active placebo group, for a subsequent mechanistic trial exploring synergistic effects of a combined intervention versus individual components alone (as described in the u2018parent`submission). For continuity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.